Further investigations to discriminate between cancer cells and the host in regulation of type I IFN signaling and expression of Serpinb9 may help in developing better stratification and understanding of how Serpinb9 inhibition might be deployed to yield more effective and specific cancer immunotherapies. Here, SERPINB9 is linked to cancer.